Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 149,413 | 146,367 | 128,184 | 138,157 | 96,116 |
| Cost of Goods | 2,802 | 7,447 | 1,932 | 7,593 | 3,191 |
| Gross Profit | 146,611 | 138,920 | 126,252 | 130,564 | 92,925 |
| Operating Expenses | 188,499 | 180,569 | 176,158 | 174,202 | 171,939 |
| Operating Income | -41,086 | -41,202 | -48,974 | -43,045 | -78,823 |
| Interest Expense | 8,129 | 7,776 | 7,616 | 6,864 | 5,895 |
| Other Income | 50,500 | -306 | 587 | 17 | 174,034 |
| Pre-tax Income | 1,285 | -49,284 | -56,003 | -49,892 | 89,316 |
| Income Tax | 789 | 671 | 273 | 102 | 180 |
| Net Income Continuous | 496 | -49,955 | -56,276 | -49,994 | 89,136 |
| Net Income | $496 | $-49,955 | $-56,276 | $-49,994 | $89,136 |
| EPS Basic Total Ops | 0.01 | -0.83 | -0.89 | -0.80 | 1.45 |
| EPS Basic Continuous Ops | 0.01 | -0.83 | -0.89 | -0.80 | 1.45 |
| EPS Diluted Total Ops | 0.01 | -0.78 | -0.89 | -0.80 | 1.40 |
| EPS Diluted Continuous Ops | 0.01 | -0.78 | -0.89 | -0.80 | 1.40 |
| EPS Diluted Before Non-Recurring Items | -0.74 | -0.79 | -0.89 | -0.80 | -1.32 |
| EBITDA(a) | $-39,959 | $-42,494 | $-51,445 | $-45,073 | $-79,206 |